论文部分内容阅读
本文通过比较短期持续皮下胰岛素泵(CSII)和每日多次皮下胰岛素注射(MDI)强化治疗初诊2型糖尿病患者的疗效及总体费用,探讨短期CSII强化降糖在治疗初诊2型糖尿病方面的优势。1资料与方法1.1临床资料选取2012年1~12月我院内分泌科住院的初诊2型糖尿病患者60例。病例纳入标准[1]:2型糖尿病的诊断符合下列标准:空腹血糖≥11.1mmol/L和(或)餐后2小时血糖≥13.9mmol/L,糖化血红蛋白(HbA1c)≥9%;所有患
This article compares the short-term sustained subcutaneous insulin pump (CSII) and subcutaneous subcutaneous insulin daily injection (MDI) intensive treatment of newly diagnosed type 2 diabetes patients and the overall cost of intensive CSII hypoglycemic treatment of newly diagnosed type 2 diabetes advantages . 1 Materials and Methods 1.1 Clinical data from January 2012 to December 2012 Department of Endocrinology hospitalized newly diagnosed type 2 diabetes in 60 patients. Cases included in the standard [1]: Type 2 diabetes diagnosis meets the following criteria: fasting blood glucose ≥ 11.1mmol / L and / or 2 hours postprandial blood glucose ≥ 13.9mmol / L, HbA1c ≥ 9%; all patients